| Статус: | Recruiting |
| Фаза: | Phase 3 |
| Начало: | 23 мая 2024 г. |
| Окончание: | 1 декабря 2028 г. |
| Описание: | Objective: to evaluate the efficacy and safety of the non-immunogenic recombinant staphylokinase with its single bolus administration in comparison with placebo in normotensive patients with intermediate high-risk pulmonary embolism (PE) |
| смотреть на ClinicalTrials.gov |
| Статус: | Recruiting |
| Фаза: | Phase 3 |
| Начало: | 26 декабря 2022 г. |
| Окончание: | 1 июля 2025 г. |
| Описание: | Objective: to evaluate the efficacy and safety of intra-arterial intrathrombus administration of the recombinant non-immunogenic staphylokinase (Fortelyzin®) in patients with acute limb ischemia (ALI) vs surgery. |
| смотреть на ClinicalTrials.gov |